Smits et al. reported that female sex in combined with MGMT methylation—epigenetic silencing for DNA repair of tumor after temozolomide treatment, which has been shown to be more sensitive to chemotherapy40,41—showed more favorable outcome to standard therapy39,42. This evidence concerns the gene MGMT and neoplasm.